L-.ALPHA.-ASPARTIC ACID MODIFICATION OF FCIII-GN3
UNII U7D4R5GV7W

Substance Identification & Data

This profile provides standardized clinical and technical data for L-.alpha.-aspartic Acid Modification Of Fciii-gn3, uniquely identified by the FDA Unique Ingredient Identifier (UNII) U7D4R5GV7W.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
U7D4R5GV7W
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
L-.ALPHA.-ASPARTIC ACID MODIFICATION OF FCIII-GN3
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C75H130N12O40
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
UJRNGGUEUYDRHR-QEARKKNCSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
171390234
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
OC([C@@H](NC(CCCc1cn(CCOCCOCCOCC(NCC(NC(COCCC(NCCOCCOCCO[C@H]2[C@H](NC(C)=O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)=O)(COCCC(NCCOCCOCCO[C@H]3[C@H](NC(C)=O)[C@@H](O)[C@@H](O)[C@@H](CO)O3)=O)COCCC(NCCOCCOCCO[C@H]4[C@H](NC(C)=O)[C@@H](O)[C@@H](O)[C@@H](CO)O4)=O)=O)=O)nn1)=O)CC(O)=O)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for L-.alpha.-aspartic Acid Modification Of Fciii-gn3. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

L-.ALPHA.-ASPARTIC ACID MODIFICATION OF FCIII-GN3

Systematic Nomenclature

N-(4-(1-(30-((2-(ACETYLAMINO)-2-DEOXY-.BETA.-D-GALACTOPYRANOSYL)OXY)-16,16-BIS(14-((2-(ACETYLAMINO)-2-DEOXY-.BETA.-D-GALACTOPYRANOSYL)OXY)-5-OXO-2,9,12-TRIOXA-6-AZATETRADEC-1-YL)-11,14,21-TRIOXO-3,6,9,18,25,28-HEXAOXA-12,15,22-TRIAZATRIACONT-1-YL)-1H-1,2,3-TRIAZOL-4-YL)-1-OXOBUTYL)-L-.ALPHA.-ASPARTIC ACID

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NLM
PubChem Compound